Pharmacy Learning Network Midwest: April 26-27, 2013

Warning message

Some features of this website require JavaScript to function properly. Some possible solutions include:
Use a browser with JavaScript enabled.
Enable JavaScript for this website.
Find more info at http://enable-javascript.com.

Pharmacy Learning Network Midwest: April 26-27, 2013

Regional Meeting

Thank you to everyone who attended PLN Midwest in Chicago, Illinois!

Attendees - Click Here to Claim Credit

Live Regional Conference for Health-System Pharmacists

April 26-27, 2013

Hyatt Regency McCormick Place
Chicago, Illinois

PLN Oncology

Pharmacy Learning Network Oncology is dedicated to educating oncology pharmacists and oncology-focused health-system pharmacists through a multitude of conferences and multimedia activities. PLN Oncology conferences focus exclusively on cancer-related topics and in 2013 will consist of 6 separate 1-hour educational sessions plus a 30-minute hot topics session.

Agenda - Friday, April 26, 2013

Session Topics Will Include:

Breast Cancer
Colorectal Cancer
Metastatic Melanoma
Multiple Myeloma
Non-Small-Cell Lung Cancer
Prostate Cancer

Oncology Faculty
Val R. Adams, PharmD, FCCP, BCOP
Associate Professor
University of Kentucky

Marlo Blazer, PharmD, BCOP
Specialty Practice Pharmacist
The Ohio State University

Christopher A. Fausel, PharmD, BCPS, BCOP
Clinical Director
Indiana University Simon Cancer Center

David G. Frame, PharmD
Assistant Professor
University of Michigan College of Pharmacy

R. Donald Harvey, PharmD, FCCP, BCPS, BCOP
Assistant Professor, Hematology/Medical Oncology
Winship Cancer Institute of Emory University

Trevor McKibbin, PharmD, MS, BCPS
Adjunct Assistant Professor
Emory University

Patrick J. Medina, PharmD, BCOP
Associate Professor
University of Oklahoma College of Pharmacy

Cindy L. O’Bryant, PharmD, BCOP, FCCP
Associate Professor
University of Colorado

Hai Tran, PharmD
Associate Professor
UT MD Anderson Cancer Center

Christine M. Walko, PharmD, BCOP
Assistant Professor
University of North Carolina School of Pharmacy

Learning Objectives

Outline the safety and efficacy of available and emerging treatment options for oncology management
Describe the roles and responsibilities of health-system pharmacists with regard to oncology patient management
Implement the latest evidence and guidelines to optimize oncology patient management strategies

PLN General Session

Attended by nearly 4400 pharmacists since its inception in 2009, the PLN General Session is now the leading regional education platform for healthsystem pharmacists. Providing 6 distinct 1-hour continuing education sessions across an array of clinical areas led by expert faculty, PLN General Session provides insight into applying evidence-based guidelines and protocols to daily practice.

Agenda - Saturday, April 27, 2013

Session Topics Will Include:

Depression
Diabetes
Fungal Infections
Hyponatremia
Medication Errors
Pharmacy Law

General Session Faculty

Peter Anderson, PharmD
Associate Professor, Department of Pharmaceutical Sciences
University of Colorado School of Pharmacy

Michael J. Cawley, PharmD, RRT, CPFT
Associate Professor of Clinical Pharmacy
University of the Sciences in Philadelphia

Susan Cornell, PharmD, CDE, FAPhA
Assistant Professor of Pharmacy Practice
Midwestern University Chicago College of Pharmacy

Scott R. Drab, PharmD, CDE, BE-ADM
Assistant Professor of Pharmacy and Therapeutics
University of Pittsburgh School of Pharmacy

Patrick R. Finley, PharmD BCPP
Professor of Clinical Pharmacy
University of California at San Francisco

Randolph V. Fugit, PharmD, BCPS
Clinical Assistant Professor, Clinical Pharmacy Practice
University of Colorado Denver

Debra Goff PharmD, FCCP
Infectious Disease Specialist
The Ohio State University

Matthew Grissinger, RPh, FISMP, FASCP
Director, Error Reporting Programs
Institute for Safe Medication Practices

James S. Lewis II, PharmD, FIDSA
Clinical Associate Professor
University of Texas College of Pharmacy

Joseph McHale, Esquire
Chair, Products Liability/Life Sciences
Stradley Ronon Stevens & Young, LLP

Mark A. Munger, PharmD, FCCP, FACC
Professor
The University of Utah College of Pharmacy

Learning Objectives

Summarize the latest clinical data regarding current and emerging therapies in depression, diabetes, fungal infections, hyponatremia, and ophthalmology
Describe the roles and responsibilities of health-system pharmacists with regard to ensuring appropriate patient management from admission through discharge
Implement evidence-based strategies for improved patient outcomes into daily practice

Hotel Information

PLN Midwest is being held at The Hyatt Regency McCormick Place in Chicago, Illinois.

The Hyatt Regency McCormick Place is located at: 2233 South Dr. Martin Luther King Jr. Drive, Chicago, Illinois, USA 60616-9985
Phone: 312-567-1234

Parking
Parking details will be provided in the attendee reminder email sent prior to the conference. PLN makes all efforts to reduce the cost of parking at the PLN Conference, but does not guarantee parking at the hotel.

Cancellation Policy

Please note that the cut-off date for cancellation is April 12, 2013. All cancellations must be received in writing (mailed or emailed) and postmarked by that date. Full registration will be refunded only to cancellations received in writing before the above date. Registrations are transferable at any time.

Intended Learners

This activity is designed for health-system pharmacists.

Activity Overview

The interactive educational conference will occur on April 26-27, 2013 at The Hyatt Regency McCormick Place. A question-and-answer session with the faculty will follow each of the 14 sessions.

To be eligible for documentation of credit, participants must attend a session in full and complete the online evaluation form. After successful completion of the evaluation form online at www.naccme.com, participants may immediately print their documentation of credit. To be eligible for credit for the live version of this activity, completed evaluations must be submitted online by May 13, 2013.

Accreditation

In support of improving patient care, North American Center for Continuing Medical Education, LLC (NACCME) is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

CPE

Each of these activities is approved for 1 contact hour (0.1 CEU) of continuing pharmacy education (UAN 0276-0000-13-002-L01-P, 0276-0000-13-003-L01-P, 0276-0000-13-004-L01-P, 0276-0000-13-005-L01-P, 0276-0000-13-007-L01-P, 0276-0000-13-008-L01-P, 0276-0000-13-009-L01-P, 0276-0000-13-010-L01-P, 0276-0000-13-011-L01-P, 0276-0000-13-012-L01-P, 0276-0000-13-025-L03-P, 0276-0000-13-026-L05-P).

Each of these activities is approved for 0.5 contact hours (0.05 CEU) of continuing pharmacy education (UAN 0276-0000-13-014-L01-P, 0276-0000-13-015-L01-P).

These educational activities are knowledge-based activities.

For questions regarding these activities, please call 609-371-1137.

Independent clinical reviewers will be disclosed in the final program materials.

Any participant wanting to file a grievance with respect to any aspect of a continuing pharmacy education activity accredited by NACCME may contact the Assistant Director, Accreditation Services, NACCME, in writing at 300 Rike Drive, Suite A, Millstone Township, NJ 08535. The Assistant Director, Accreditation Services will review the grievance and respond within 30 days of receiving the written statement. If the participant is unsatisfied with the response, an appeal to the Executive Director, Accreditation Services, NACCME, may be made for a second level of review.

ADA Statement

North American Center for Continuing Medical Education complies with the legal requirements of the Americans with Disabilities Act and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please call 609-371-1137.

Hardware/Software Requirements

The evaluations are accessible after the activity via a PC (Windows 2000/XP/Vista/7) or Mac (Mac OS 10.x or later) computer with current versions of the following browsers: Internet Explorer, Mozilla Firefox, Google Chrome or Safari. A PDF reader is required for print publications. Please direct technical questions to webmaster@naccme.com.

Planning Committee

The planning committee comprises Val R. Adams, PharmD, FCCP, BCOP, Peter Anderson, PharmD, Marlo Blazer, PharmD, BCOP, Michael J. Cawley, PharmD, RRT, CPFT, Timothy Cernohous, PharmD, Susan Cornell, PharmD, CDE, FAPhA, Scott R. Drab, PharmD, CDE, BE-ADM, Christopher A. Fausel, PharmD, BCPS, BCOP, Patrick R. Finley, PharmD BCPP, David G. Frame, PharmD, Randolph V. Fugit, PharmD, BCPS, Debra Goff PharmD, FCCP, Matthew Grissinger, RPh, FISMP, FASCP, R. Donald Harvey, PharmD, FCCP, BCPS, BCOP, James S. Lewis II, PharmD, FIDSA, Joseph McHale, Esquire, Trevor McKibbin, PharmD, MS, BCPS, Patrick J. Medina, PharmD, BCOP, Mark A. Munger, PharmD, FCCP, FACC, Randall Seifert, PharmD, Hai Tran, PharmD, Christine M. Walko, PharmD, BCOP; and Kristin Ciszeski, Mary Johnson, Mike Kearney, Nick Lombardi, Randy Robbin, and John Savage, NACCME.

Financial Disclosure and Conflicts of Interest

According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are indentified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.

All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.

NACCME requires faculty to inform participants whenever off-label/unapproved uses of drugs and/or devices are discussed in their presentations

Financial disclosures and conflicts of interest, and any off-label/unapproved uses of drugs and/or devices will be disclosed in the final activity materials.

NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. NACCME and our joint sponsors will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the appropriate accrediting agency.

NACCME maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Copyright © 2013 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education.

Grant Support

Supported in part by independent educational grants from Millennium, The Takeda Oncology Company, Novartis Pharmaceuticals Corporation, Otsuka America Pharmaceutical, Inc., Alcon Laboratories, Inc., Bayer HealthCare Pharmaceuticals Inc, and Sanofi US and Regeneron Pharmaceuticals.